ARKK lost 14.91% over 5 years as QQQ gained 111.60%, though ARKK led over 5 days, 1 month, and 6 months. QQQ also led year to date and over 1 year, and the story reports no new change at ARKK.
QQQ's 5-year gain was 111.60%, compared with ARKK's 14.91% loss. QQQ also led year to date and over 1 year, but ARKK led over 5 days, 1 month, and 6 months. Wood described different investment focuses and cited stronger ARK rankings in other periods. Those claims add context, but the story reports no new change at ARKK.
QQQ gained 111.60% over 5 years and led year to date and over 1 year, but ARKK led over 5 days, 1 month, and 6 months. The story reports no new change at QQQ.
Tempus AI is named among ARKK's healthcare and biotech holdings, but the story gives no new company result or change. It does not change Tempus AI's outlook.
CRISPR Therapeutics is named among ARKK's healthcare and biotech holdings, but the story gives no new company result or change. It does not change CRISPR Therapeutics' outlook.
Twist Bioscience is named among ARKK's healthcare and biotech holdings, but the story gives no new company result or change. It does not change Twist Bioscience's outlook.
Follow ARK Innovation ETF (ARKK) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ARKK